InMed Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

InMed Pharmaceuticals

15/02/2022 14:30

* InMed Pharmaceuticals Inc  INM.OQ  reported a quarterly
adjusted
loss of 31 cents​​ per share for the quarter ended in December.
The mean expectation of two analysts for the quarter was for a
loss of 23 cents per share.
    * Revenue was $4.22 thousand​;  analysts expected $125.00
thousand. 
    * InMed Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 31 cents​.
    * The mean earnings estimate of analysts had risen by
about 16.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * InMed Pharmaceuticals Inc shares had fallen by 13.0% this
quarter.
    * The company reported a quarterly loss of $4.28 million.
    * Wall Street's median 12-month price target for InMed
Pharmaceuticals Inc is $6.75 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated February 15 at 02:30 p.m.
 ​All figures in US dollars unless otherwise stated